麻醉药物预防心脏手术肺损伤(APLICS):一项随机对照试验方案
APLICS是一项前瞻性随机对照试验,纳入成人心脏手术患者,比较七氟烷与丙泊酚术中麻醉维持对体外循环后肺炎症的影响。主要结局为再灌注后2-4小时支气管肺泡灌洗液中TNFα浓度差异,次要结局包括其他灌洗液及全身炎症标志物和术后肺部并发症发生率。
要点
- 七氟烷与丙泊酚术中维持麻醉,按方案通气以减少呼吸机相关肺损伤和高氧影响。
- 主要结局为体外循环后支气管肺泡灌洗液TNFα浓度组间差异。
- 次要结局包括其他灌洗液及全身炎症标志物和术后肺部并发症发生率。
核心结论
- APLICS研究七氟烷麻醉维持能否调节体外循环心脏手术期间的肺部炎症,以及该潜在效应能否转化为术后肺部并发症的减少。
研究设计与样本
- 前瞻性随机对照试验,纳入成人心脏手术患者,随机分为七氟烷组或丙泊酚组行术中麻醉维持。
- 两组均按旨在减少呼吸机诱导肺损伤和高氧影响的方案进行通气。
- 在麻醉诱导后及肺再灌注后2-4小时进行支气管肺泡灌洗和血液采样。
关键数值与推荐
- 主要结局为组间体外循环后肺炎症程度差异,以支气管肺泡灌洗液TNFα浓度定义。
- 次要结局包括其他相关灌洗液及全身炎症标志物的差异和术后肺部并发症发生率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing cardiac surgery with cardiopulmonary bypass are at an increased risk of developing postoperative pulmonary complications, potentially leading to excess morbidity and mortality. It is likely that pulmonary ischemia-reperfusion (IR) injury during cardiopulmonary bypass is a major contributor to perioperative lung injury. Therefore, interventions that can minimize IR injury would be valuable in reducing the excess burden of this potentially preventable disease process. Volatile anesthetics including sevoflurane have been shown in both preclinical and human trials to effectively limit pulmonary inflammation in a number of settings including ischemia-reperfusion injury. However, this finding has not yet been demonstrated in the cardiac surgery population. The Anesthetics to Prevent Lung Injury in Cardiac Surgery (APLICS) trial is a randomized controlled trial (RCT) investigating whether sevoflurane anesthetic maintenance can modulate pulmonary inflammation occurring during cardiac surgery with cardiopulmonary bypass and whether this potential effect can translate to a reduction in postoperative pulmonary complications. METHODS: APLICS is a prospective RCT of adult cardiac surgical patients. Participants will be randomized to receive intraoperative anesthetic maintenance with either sevoflurane or propofol. Patients in both groups will be ventilated according to protocols intended to minimize the influences of ventilator-induced lung injury and hyperoxia. Bronchoalveolar lavage (BAL) and blood sampling will take place after anesthetic induction and 2-4 h after pulmonary reperfusion. The primary outcome is a difference between groups in the degree of post-bypass lung inflammation, defined by BAL concentrations of TNFα. Secondary outcomes will include differences in additional relevant BAL and systemic inflammatory markers and the incidence of postoperative pulmonary complications. DISCUSSION: APLICS investigates whether anesthetic choice can influence lung inflammation and pulmonary outcomes following cardiac surgery with cardiopulmonary bypass. A positive result from this trial would add to the growing body of evidence describing the lung protective properties of the volatile anesthetics and potentially reduce unnecessary morbidity for cardiac surgery patients. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02918877 . Registered on 29 September 2016.
引用
- O'Gara B, Subramaniam B, Shaefi S, et al. Anesthetics to Prevent Lung Injury in Cardiac Surgery (APLICS): a protocol for a randomized controlled trial. Trials. 2019. PMID: 31151474. doi:10.1186/s13063-019-3400-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。